Ümmühan Ünlü

Mrs. Ümmühan Ünlü

Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BÖBurcu Özkan
Burcu Özkan
EAEbru Altuntas
Ebru Altuntas
ÜÜÜmmühan Ünlü
Ümmühan Ünlü
HDHasan Huseyin Dogan
Hasan Huseyin Dogan
YOYildiz Ozsoy
Yildiz Ozsoy
RKRabia Çakır Koç
Rabia Çakır Koç
The human respiratory syncytial virus (hRSV) is a major cause of serious lower respiratory infections and poses a considerable risk to public health globally. Only a few treatments are currently used to treat RSV infections, and there is no RSV vaccination. Therefore, the need for clinically applicable, affordable, and safe RSV prevention and treatment solutions is urgent. In this study, an ion-activated in situ gelling formulation containing the broad-spectrum antiviral 18β-glycyrrhetinic acid (GA) was developed for its antiviral effect on RSV. In this context, pH, mechanical characteristics, ex vivo mucoadhesive strength, in vitro drug release pattern, sprayability, drug content, and stability were all examined. Rheological characteristics were also tested using in vitro gelation capacity and rheological synergism tests. Finally, the cytotoxic and antiviral activities of the optimized in situ gelling formulation on RSV cultured in the human laryngeal epidermoid carcinoma (HEp-2) cell line were evaluated. In conclusion, the optimized formulation prepared with a combination of 0.5% w/w gellan gum and 0.5% w/w sodium carboxymethylcellulose demonstrated good gelation capacity and sprayability (weight deviation between the first day of the experiment (T0) and the last day of the experiment (T14) was 0.34%), desired rheological synergism (mucoadhesive force (Fb): 9.53 Pa), mechanical characteristics (adhesiveness: 0.300 ± 0.05 mJ), ex vivo bioadhesion force (19.67 ± 1.90 g), drug content uniformity (RSD%: 0.494), and sustained drug release over a period of 6 h (24.56% ± 0.49). The optimized formulation demonstrated strong anti-hRSV activity (simultaneous half maximal effective concentration (EC50) = 0.05 µg/mL; selectivity index (SI) = 306; pre-infection EC50 = 0.154 µg/mL; SI = 100), which was significantly higher than that of ribavirin (EC50 = 4.189 µg/mL; SI = 28) used as a positive control against hRSV, according to the results of the antiviral activity test. In conclusion, this study showed that nasal in situ gelling spray can prevent viral infection and replication by directly inhibiting viral entry or modulating viral replication.

31 January 2024 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
NONurullah Okumuş
Nurullah Okumuş
SESevim Feyza Erdoğmuş
Sevim Feyza Erdoğmuş
HDHasan Huseyin Dogan
Hasan Huseyin Dogan
ÖAÖzlem Erdal Altıntaş
Özlem Erdal Altıntaş
SÇSefa Çelik
Sefa Çelik
ÜÜÜmmühan Ünlü
Ümmühan Ünlü

24 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
BÖBurcu Özkan
Burcu Özkan
EAEbru Altuntas
Ebru Altuntas
ÜÜÜmmühan Ünlü
Ümmühan Ünlü
HDHasan Huseyin Dogan
Hasan Huseyin Dogan
YOYildiz Ozsoy
Yildiz Ozsoy
RKRabia Çakır Koç
Rabia Çakır Koç
The human respiratory syncytial virus (hRSV) poses a serious risk to global public health and is a significant cause of severe lower respiratory infections. There are currently only a few therapies available to treat RSV infections, as well as no RSV vaccinations. Therefore, there is an urgent demand for clinically feasible, safe, and affordable RSV prevention and treatment alternatives. In this study, an ion-activated in situ gel comprising broad-spectrum antiviral 18β-glycyrrhetinic acid (GA) for antiviral action on RSV was developed. In this content, mechanical properties, sprayability, drug content, pH, ex vivo mucoadhesive strength, in vitro drug release pattern, and stability were all examined. Rheological properties were also tested by utilizing in vitro gelation capacity and rheological synergism tests. Finally, the optimized in situ gel's cytotoxic and antiviral activities on RSV cultured in human laryngeal epidermoid carcinoma (HEP-2) cell line were evaluated. In conclusion, the optimized in situ gel prepared with a combination of 0.5%w/w gellan gum and 0.5%w/w sodium carboxymethylcellulose demonstrated good gelation capacity and sprayability (weight deviation between T0 and T14: 0.34%), desired rheological synergism (mucoadhesive force (Fb): 9.53), mechanical characteristics (adhesiveness: 0.300 mJ ± 0.05), ex vivo bioadhesion force (19.67 g ± 1.90), drug content uniformity (RSD%: 0.494), and sustained drug release over period of 168 h (101.57% ± 0.53). The antiviral activity test results showed that the optimized in situ gel had strong anti-HRSV activity (EC50 simultaneous = 0.05 µg/ml, SI = 306; EC50 preinfection = 0.154 µg/ml, SI= 100) which was significantly higher than that of ribavirin (EC50 =4.189 µg/ml; SI= 28) used as a positive control against hRSV. In conclusion, this research has demonstrated the formulation of an effective antiviral nasal spray that has the ability to possess both prophylactic and virucidal activity.

31 July 2025 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
EÖErkan ÖZBAY
Erkan ÖZBAY
ÜÇÜlkü Çömelekoğlu
Ülkü Çömelekoğlu
FSFATMA SÖĞÜT
FATMA SÖĞÜT
MYMetin Yildirim
Metin Yildirim
SKSerkan KÜÇÇÜKTÜRK
Serkan KÜÇÇÜKTÜRK
ÜÜÜmmühan Ünlü
Ümmühan Ünlü